201 related articles for article (PubMed ID: 29165176)
1. The different roles of innate immune receptors in inflammation and carcinogenesis between races.
Yamaguchi N; Suzuki Y; Mahbub MH; Takahashi H; Hase R; Ishimaru Y; Sunagawa H; Watanabe R; Eishi Y; Tanabe T
Environ Health Prev Med; 2017 Oct; 22(1):70. PubMed ID: 29165176
[TBL] [Abstract][Full Text] [Related]
2. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
Le Bourhis L; Benko S; Girardin SE
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
[TBL] [Abstract][Full Text] [Related]
4. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
Correa RG; Milutinovic S; Reed JC
Biosci Rep; 2012 Dec; 32(6):597-608. PubMed ID: 22908883
[TBL] [Abstract][Full Text] [Related]
5. NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.
Jeon DI; Park SR; Ahn MY; Ahn SG; Park JH; Yoon JH
Int J Mol Med; 2012 Apr; 29(4):699-703. PubMed ID: 22218461
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
Yan R; Liu Z
Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1).
Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M
Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936
[TBL] [Abstract][Full Text] [Related]
9. Intracellular NOD-like receptors in host defense and disease.
Kanneganti TD; Lamkanfi M; Núñez G
Immunity; 2007 Oct; 27(4):549-59. PubMed ID: 17967410
[TBL] [Abstract][Full Text] [Related]
10. Intracellular NOD-like receptors in innate immunity, infection and disease.
Franchi L; Park JH; Shaw MH; Marina-Garcia N; Chen G; Kim YG; Núñez G
Cell Microbiol; 2008 Jan; 10(1):1-8. PubMed ID: 17944960
[TBL] [Abstract][Full Text] [Related]
11. NOD-like receptors--pivotal guardians of the immunological integrity of barrier organs.
Rosenstiel P; Schreiber S
Adv Exp Med Biol; 2009; 653():35-47. PubMed ID: 19799110
[TBL] [Abstract][Full Text] [Related]
12. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
Caruso R; Warner N; Inohara N; Núñez G
Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
[TBL] [Abstract][Full Text] [Related]
13. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
14. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.
Wong CK; Hu S; Leung KM; Dong J; He L; Chu YJ; Chu IM; Qiu HN; Liu KY; Lam CW
Cell Mol Immunol; 2013 Jul; 10(4):317-29. PubMed ID: 23524653
[TBL] [Abstract][Full Text] [Related]
15. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.
Tattoli I; Travassos LH; Carneiro LA; Magalhaes JG; Girardin SE
Semin Immunopathol; 2007 Sep; 29(3):289-301. PubMed ID: 17690884
[TBL] [Abstract][Full Text] [Related]
16. NOD1 activators link innate immunity to insulin resistance.
Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
[TBL] [Abstract][Full Text] [Related]
17. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
Kvarnhammar AM; Petterson T; Cardell LO
Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.
Tanabe T; Yamaguchi N; Matsuda K; Yamazaki K; Takahashi S; Tojo A; Onizuka M; Eishi Y; Akiyama H; Ishikawa J; Mori T; Hara M; Koike K; Kawa K; Kawase T; Morishima Y; Amano H; Kobayashi-Miura M; Kakamu T; Nakamura Y; Asano S; Fujita Y
Int J Hematol; 2011 Jun; 93(6):771-778. PubMed ID: 21573891
[TBL] [Abstract][Full Text] [Related]
19. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
20. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
